2,5-Dimethyl-4-ethyloxazole
| Common Name: |
2,5-Dimethyl-4-ethyloxazole |
| IUPAC Name: |
4-ethyl-2,5-dimethyl-1,3-oxazole |
| Molecular Formula: |
C7H11NO |
| SMILES: |
CCC1=C(OC(=N1)C)C |
| Inchi: |
1S/C7H11NO/c1-4-7-5(2)9-6(3)8-7/h4H2,1-3H3 |
| Inchi Key: |
YZZBROGKUWYQOL-UHFFFAOYSA-N |
| Cas No: |
30408-61-8 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
2 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
125.17 |
| Mass (g/mol) |
125.084 |
| Molar Refractivity |
36.21 |
| Net Charge |
|
| HBD |
|
| HBA |
2 |
| Rt Bonds |
1 |
| Rings |
1 |
| TPSA |
26.03 |
| Hetero Atoms |
2 |
| Heavy Atoms |
9 |
| Aromatic Heavy Atoms |
5 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
150 |
| Vapor Pressure (mmHg@25.00 °C) |
3.106 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.57 |
| LogP |
1.854 |
| iLOGP |
2.20 |
| XLOGP3 |
1.97 |
| WLOGP |
1.85 |
| MLOGP |
0.67 |
| ESOL Log S |
-2.20 |
| ESOL Solubility (mg/ml) |
0.786 |
| ESOL Solubility (mol/l) |
0.006 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-2.14 |
| Ali Solubility (mg/ml) |
0.9 |
| Ali Solubility (mol/l) |
0.01 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-2.76 |
| Silicos-IT Solubility (mg/ml) |
0.22 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.66 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.619 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.09 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
